Longer dupilumab dosing intervals in adult patients with atopic dermatitis: experience from a French multicentre retrospective cohort study

Br J Dermatol. 2022 Oct;187(4):602-603. doi: 10.1111/bjd.21628. Epub 2022 Jul 11.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Adult
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Dermatitis, Atopic* / drug therapy
  • Humans
  • Retrospective Studies

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • dupilumab